Osseointegrated Transcutaneous Device for Amputees: A Pilot Large Animal Model by Grisez, Brian T et al.
Faculty Scholarship 
2018 
Osseointegrated Transcutaneous Device for Amputees: A Pilot 
Large Animal Model 
Brian T. Grisez 
Andrew E. Hanselman 
Karim W. Boukhemis 
Trapper A.J. Lalli 
Brock A. Lindsey 
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications 
 Part of the Orthopedics Commons 
Research Article
Osseointegrated Transcutaneous Device for Amputees:
A Pilot Large Animal Model
Brian T. Grisez, Andrew E. Hanselman, KarimW. Boukhemis,
Trapper A. J. Lalli, and Brock A. Lindsey
Department of Orthopaedics, West Virginia University, PO Box 9196, Morgantown, WV 26506-9196, USA
Correspondence should be addressed to Brock A. Lindsey; blindsey@hsc.wvu.edu
Received 17 April 2018; Revised 20 July 2018; Accepted 5 August 2018; Published 13 September 2018
Academic Editor: Allen L. Carl
Copyright © 2018 Brian T. Grisez et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Traditional above-the-knee amputation prosthetics utilize a stump-socket interface that is well-known for skin/socket problems,
sitting difficulty, disuse osteopenia, and increased work of ambulation. As a result, we evaluated a novel osseointegrated
transcutaneous implant in a large animal. The implant was designed to promote osseointegration at the bone-implant interface
and minimize complications. As proof of concept, four Dorset sheep underwent a two-stage surgery for forelimb placement of an
osseointegrated transcutaneous implant utilizing Compress technology (Biomet, Inc., Warsaw, IN). Two sheep received a long
anchor plug (90mm long x 9mm in diameter) and two received a short anchor plug (46mm long x 9mm in diameter). Sixteen
weeks after the initial surgery, the operative limbs, along with the attached implant, underwent radiographic and histological
analysis for osseointegration. Periprosthetic fractures occurred in the two animals that received the longer internal prosthesis; one
healed with splinting and the other animal underwent a second surgical procedure to advance the amputation site more proximal.
No fractures occurred in the shorter internal prosthesis group. There was no histological evidence of infection and none of the
transcutaneous adapters failed. Bone-implant osseointegration was demonstrated in two of three limbs that underwent histological
analysis. This unique implant demonstrated osseointegration without transcutaneous adapter failure, all while displaying minimal
infection risk from the outside environment. Although it involved short-term follow-up in a limited number of animals, this pilot
study provides a platform for further investigation into the valid concept of using Compress technology as an endo-exo device.
1. Introduction
Above-the-knee amputations have traditionally utilized a
stump-socket interface for prosthetic attachment and ambu-
lation. Unfortunately, this type of prosthetic design is associ-
ated with numerous problems. Skin changes (i.e., ulcerations,
cysts, and contact dermatitis), increased energy expenditure
during ambulation, disuse osteopenia, and sitting difficulty
are the substantial issues [1, 2]. These factors, in turn, may
lead to limited activity levels and decreased autonomy by
amputees [3].
Osseointegrated transcutaneous femoral prosthetics were
developed in the 1990s to address these problems [4].
Based on the work of Per-Ingvar Bra˚nemark, who coined
the term “osseointegration” with the development of dental
implants, the basic prosthetic design consists of an internal
intramedullary component, a transcutaneous component,
and a detachable external prosthesis [5]. In comparison with
stump-socket fixation, these devices have been shown to
improve limb control and sensory perception, decrease oxy-
gen consumption with ambulation, improve sitting comfort,
and allow more efficient prosthetic donning and doffing [6].
Unfortunately, the transcutaneous nature and design of these
implants predispose the amputee to infection, bone fracture,
bone loss due to stress shielding, and implant failure [7, 8].
Currently, there are only a few osseointegrated transcuta-
neous prosthetic systems in use for humans and none of these
systems are approved for general use in the United States.
The current implant designs, although successful in their own
ways, have substantial room for improvement, specifically
in regard to the success of the osseointegration, the balance
between the amount of bone stock required for implantation
and removal of the implant, and the sturdiness of the
transcutaneous component. As a result, we believe that large
Hindawi
Advances in Orthopedics
Volume 2018, Article ID 4625967, 9 pages
https://doi.org/10.1155/2018/4625967
2 Advances in Orthopedics
animal models are the appropriate first step in evaluation
of a novel implant system utilizing Compress technology
(Biomet Inc., Warsaw, IN). In 2003, the Food and Drug
Administration (FDA) approved the Compress technology
for use in limb-salvage procedures; this device provides a
constant compressive load across the bone-implant interface.
This design may act as a seal for the intramedullary canal,
limiting ascending infection from the outside, while allowing
for shorter working femoral length and preserving more
bone stock if removal is necessary, all while avoiding stress
shielding completely [9].
The overall goal of our study was to evaluate a unique
osseointegrated transcutaneous implant utilizing Compress
technology and test it using a large animalmodel. Specifically,
we wanted to use this pilot study as a proof-of-concept
for acquisition of data that would help us further this
research. The specific aims of this study include displaying
the ability to surgically implant this novel design, evaluating
the bone implant/interface by histology showing potential
for complete osseointegration,minimizing infection risk, and
obtaining robustness of the transcutaneous adapter without
failure.
2. Materials and Methods
2.1. Implant Design. A novel intraosseous transcutaneous
prosthesis was developed utilizing Compress technology
(Figure 1). It consisted of a proximal intramedullary anchor
plug equipped with transverse, bicortical pins to provide
rotational stability. The anchor plug was continuous with a
Compress titanium spindle with plasma sprayed titanium
porous surface at the bone interface that provided approx-
imately 600 pounds of force (lbf ) across the bone-implant
interface, in order to promote osseointegration. Compression
was accomplished through the use of Belleville washers
and a locking nut within the prosthesis itself. The internal
mechanism of the spindle also contained a silicone gasket
to make the seal from the internal prosthesis and medullary
canal air and water tight. The spindle/anchor plug device
allowed connection to a transcutaneous adapter. This sisal
polished cobalt chrome adapter communicated with the
outside environment to allow attachment of different external
prostheses. Based on the results of prior studies [10, 11],
the spindle and transcutaneous adapter were constructed
to be smooth and highly polished, in an attempt to pro-
mote epithelialization of the skin-implant interface and limit
abscess formation creating a stable stoma at the skin-implant
interface.
2.2. Animal Surgery. Institutional Animal Care and Use
Committee (IACUC) approval was obtained prior to study
initiation. Four three-year-old, skeletally mature, female
Dorset sheep (Archer Farms, Inc., Darlington, MD) (average
weight = 120 lbs) underwent a two-stage implant procedure.
The first stage consisted of surgical amputation of the fore-
limb at the distal radius, placement of the Compress internal
prosthesis, polyethylene cap, and closure of the soft-tissue
envelope over a polyethylene spacer with an extraction hole
distally for removal of the spacer percutaneously (Figures 1
and 2). Six weeks later, a second surgical procedure consisted
of externalization of the coupling device through the forma-
tion of a transcutaneous portal, removal of the polyethylene
spacer, and attachment of the transcutaneous prosthesis
(Figures 1 and 2). The forelimb of the sheep was chosen
due to its vertical alignment, compared to the hindlimb,
thus more closely mimicking the forces experienced by the
human femur during stance and movement. Two sheep
(1A and 1B) received a longer anchor plug (90mm) and
two sheep (2A and 2B) received a shorter anchor plug
(46mm). This change was made because the size and bow
of the forelimb contributed to the fractures experienced in
the first group. Preoperative and intraoperative anesthesia
consisted of xylazine (0.02-0.2mg/kg, IV), ketamine (7mg/kg,
IV), diazepam (0.3mg/kg, IV), and isoflurane (5% induction
and 1.5-4% maintenance, inhalation). Preoperative analgesia
consisted of lidocaine (2%, 8-10mL, SQ) and bupivacaine (up
to 15mL, SQ). Postoperative analgesia consisted of fentanyl
(50micrograms/hr, transdermal) immediately postoperatively
and morphine (up to 10mg daily, IM) and butorphanol
(up to 20mg, SQ or IV). Other drugs included excenel
(2.2mg/kg, SQ) preoperatively and for three days post-
operatively, vitamin B complex (5mL, SQ) for four days
postoperatively, omeprazole (1.0mg/kg, PO) for seven days
postoperatively, probiotics (1.0mg/kg, PO) for three days
postoperatively, and kaopectate (4oz, PO) for three days
postoperatively.
2.3. Postoperative Animal Care. During the six-week period
between the first and second procedures, the animals were
casted and limitation of weightbearing was attempted to
limit rotational stress on the device until osseointegration
began to occur at the bone spindle interface. However, nearly
all animals used the experimental forelimb almost immedi-
ately. After the second surgical procedure, the animals were
allowed to bear weight as tolerated. Throughout the duration
of the study, animals were housed at a local research farm
equipped to maintain large animals. Daily care was provided
by staff trained in this particular species, with veterinarian
care provided as needed. Daily assessment from the start of
the study included ambulation ability, use of the prosthesis,
bone fracture, and implant failure. Clinical assessment for
infection included presence of fever, warmth or swelling of
the limb, draining of purulent material from the wound after
the first surgery and observation of frank pus and necrotic
tissue at the time of the second surgery. Ten weeks after
the second stage, or sixteen weeks from the first stage, the
sheep were euthanized (Pentobarbital/Euthasol/Fatal-Plus,
100mg/kg, IV) and their operative limbs were harvested.
2.4. Limb Analysis. Plain film radiographic images of the
harvested limbs with the retained internal prostheses were
performed immediately after euthanasia. The limbs with
implanted prosthesis were soaked in 10% neutral buffered
formalin for 72 hours, then wrapped in formalin-dampened
gauze, and sent to the Histomorphometry and Molecular
Analysis Core at University of Alabama at Birmingham for
histological processing. Here, they were embedded in poly-
methyl methacrylate (PMMA) and cut into four quadrants
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(a) (b) (c)
Figure 1: (a) During the first procedure, the spindle and anchor plug are implanted. A cap is placed over the spindle and the soft tissues
are closed to allow for provisional healing. (b) The cap is removed at the second surgery and the taper fit transcutaneous adapter is applied.
(c) A cross section of the implant demonstrating the compression mechanism. Compression of the spindle against the bone is generated by
tightening of the anchor plug locking nut against the Belleville washers. The anchor plug is secured proximally by cross pins (not shown).
A silicone gasket fits within the distal end of the spindle to deter bacterial migration proximally into the canal. The taper fit transcutaneous
adapter is attached over the distal aspect of the spindle.
(a) (b)
Figure 2: Radiographic images of the staged implant procedure. (a) Implant of spindle components with polyethylene cap and primary
wound closure (b) Removal of polyethylene cap which is replaced with a tapered-fit transcutaneous adapter.
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Table 1: Results overview.
Sheep Infection Fracture Implant Failure Osseointegration
1A Yes Yes No n/a
1B No Yes No Yes
2A No No No Yes
2C No No No No
Figure 3: Two animals sustained fractures of their radius after the first surgery. It was presumed that eccentric reaming (left) due to the bow
of the radius created a stress riser and resultant spiral type fracture (right)
along their longitudinal and transverse axes in a 90∘-90∘ fash-
ion using an EXAKT diamond band saw. One approximately
100 um section was then prepared from each quadrant using
the EXAKT grinding system and stained with methylene
blue/basic fuchsin stain (hematoxylin and eosin-like stain).
They were specifically evaluated for infection (assessing for
inflammation at the interface), osseointegration at the bone-
spindle interface (defined as >50% surface area of the bone
with contact to the spindle), and epithelialization at the skin-
implant interface.
3. Results (Table 1)
Sheep 1A received the longer anchor plug (90mm). Seventeen
days after the first stage surgical procedure, the animal
sustained a spiral type fracture proximal to the implant (Fig-
ure 3). Although casted after the initial surgery, the animal
was full weight bearing immediately after surgery and did not
show any signs of splinting or lameness of the limb prior to
the fracture. Three days later, a second surgical amputation
was performedmoving the internal prosthesismore proximal
toward the shoulder (humerus) using the same prosthesis
because of a custom design. An autoclave was not available at
the time of the surgery and the implant could not be sterilized.
Six weeks later, the second stage procedure was performed
to externalize the internal prosthesis. At that time, abscess
formation was appreciated in the soft tissue surrounding the
extramedullary portion of the implant. It appeared to be a
deep infection with extraosseous involvement. We contin-
ued with the externalization procedure and postoperatively
treated the animal with an antibiotic (enrofloxacin) for six
weeks. Upon conclusion of the study, there was no clinical
evidence of infection; no wound culturing was performed at
the time of the initial infection or at the completion of the
study. Since we deviated from the original research protocol
by performing a revision of the first stage, we only performed
gross histological analysis of the limb after euthanasia. This
analysis demonstrated good evidence of epithelialization
along the skin-implant interface with minimal downgrowth
(Figure 4). No osseous histological analysis was completed on
this animal because of such gross deviation from the protocol
and it was felt that any further analysis would potentially skew
any observations or results.
Sheep 1B received the longer anchor plug (90mm) (Fig-
ure 5(a)). Similar to Sheep 1A, the animal sustained a spiral
type fracture proximal to the implant 13 days after the second
stage procedure. Unlike Sheep 1A, the implant was retained
and the limbwas splinted providing rotational control, as well
as complete nonweightbearing of the limb (Figure 5(b)). After
the limb was harvested, histological analysis revealed bone-
implant osseointegration in all four quadrants (Figure 5(c)).
Due to the unique surface design of the Compress spin-
dle base (a solid structure with macro- and microtexture),
osseointegration is deemed complete with bony onlay at the
spindle within themicrotexture of the implant. Although this
process takes years to complete, histological evidence of bony
apposition is consistent with the process of osseointegration
occurring. No osseointegration will occur along the anchor
plug as this is a smooth surface and acts as a traction bar
between the femur and the spindle.
No infection was appreciated clinically or histologically.
Figure 5(d) demonstrates the animal weightbearing without
restriction on the transcutaneous adapter after the second
surgery.
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Figure 4: This figure shows the transcutaneous adaption of the skin epithelialization at the implant-skin interface (Sheep 1A).
(a) (b)
(c) (d)
Figure 5: (a)This figure shows radiographs of the implant in Sheep 1B. (b)This figure displays the splinted extremity of the fractured animal,
Sheep 1B. (c) This figure demonstrates histological analysis of the osseointegration at all four quadrants in Sheep 1B. (d) This photograph
taken after the second surgery demonstrates the animal weight bearing without restriction on the transcutaneous adapter.
Sheep 2A received the shorter internal implant (46mm)
(Figure 6(a)). No fractures or implant failure occurred; no
infection was detected clinically or histologically. Osseoin-
tegration was appreciated on histological analysis in all four
bone-implant quadrants (Figure 6(b)).
Sheep 2B received the shorter internal implant (46mm)
(Figure 7(a)). During the initial operative procedure, a drill
bit broke due to surgeon error during implantation of a
transverse pin; consequently, we were unable to place a pin
at that site. No fractures occurred and no infection was
detected clinically or histologically. Osseointegration was not
appreciated on histological analysis in three of the four bone-
implant quadrants; although bony down-growth toward the
spindle interface is apparent (Figure 7(b)).
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(a) (b)
Figure 6: (a)This figure shows radiographs of the implant in Sheep 2A. (b) Histological analysis of Sheep 2A demonstrating osseointegration
at all four quadrants.
(a) (b)
Figure 7: (a) This figure shows radiographs of the implant in Sheep 2B. (b) Histological analysis of Sheep 2B demonstrating tenuous
osseointegration in the lower left hand quadrant but only bony encroachment toward the spindle base in the other three quadrants without
fulminant osseointegration.
4. Discussion
The aim of our pilot study was to develop a unique osseoin-
tegrated transcutaneous implant utilizing Compress tech-
nology and test it in a small number of large animals over
a short time period for acquisition of data that would help
us develop a platform to continue this research. Specifically,
we wanted the implant to demonstrate the potential for
complete osseointegration at the bone-implant interface,
display limited infection risk from the outside environment,
and contain a stout enough transcutaneous adapter to prevent
implant failure. Two of three limbs that underwent histology
demonstrated bone-implant interface osseointegration in all
four quadrants. In one limb that did not demonstrate bony
apposition at the implant interface, an intraoperative surgeon
error resulted in a reduction in the number of transverse
pins that normally provide rotational control and increased
stability. Modifying the anchor plug (from 10mm to 9mm) to
decrease the diameter created a ridge for the drill bit to catch
causing it to break, which produced a significant amount of
torque on the implant.
The two animals with the longer implant sustained
fractures. One had a revision wherein the internal prosthesis
was placed in the humerus and one healed after application of
a splint that restricted weightbearing and provided rotational
control. No fractures were observed in the shorter implant
group. No evidence of transcutaneous adapter implant failure
was observed in any of the animals. We believe the fractures
occurred because of a distinct bow in the animal’s radius,
which did not allow a straight anchor plug of 90mm to be
implanted without some eccentric reaming of the cortical
bone (Figure 3). This reaming created a stress riser and as
we could not limit the animal’s weightbearing, the bone
fractured. Future studies could involve a time period of
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weight bearing restriction postoperatively as part of the
established protocol.
No histological evidence of acute infection, presence of
acute inflammatory cells (polymorphonuclear neutrophils),
abscess formations, or bacteria was noted by histology (Sheep
1B, 2A, and B). Although some chronic inflammatory cells
were noted, this was likely a mild foreign body reaction,
which was consistently noted in all the specimens analyzed.
One animal demonstrated clinical abscess formation prior
to the second stage procedure. However, this complication
was likely related to revision surgery since the same internal
device was used and unable to be resterilized appropriately,
which would logically lead to a higher infection risk. This
infection was deep and appeared to be extraosseous in
nature. Despite a contaminated environment, there were also
no superficial infections. The infection responded well to
antibiotic treatment and, even after being off antibiotics, the
transcutaneous stoma showed no signs of infection.
Creating a stable stoma around the implant is an impor-
tant feature in the development of a successful transcutaneous
device. Aschoff et al. reported early device designs that
utilized a porous transdermal component that was plagued
with issues including skin irritation, patient discomfort,
hypergranulation, and infection [10, 11]. Pendegrass and
colleagues have done extensive investigation into implant-
skin interface healing. Common reasons for failure at this
interface include marsupialization, avulsion, and infection.
Their work has indicated that smooth surfaces improve ker-
atinocyte adhesion and if dermal, not epithelial, attachment
occurs and epithelial down growth is prevented [12, 13]. The
histology from our implant shows epithelialization of the
skin around the transcutaneous adaptor with a stable stoma
and minimal down growth at the implant, skin/air/interface.
Although this device hasmaintained the idea of a stable stoma
concept with no epidermal integration into the device itself,
others (Pitkin et al.) have utilized titanium based pylons that
have had some success in feline animal studies which shows
some promise [14]. However, no large animal or human
studies have been published as of yet.
There are few research groups implanting human devices
throughout the world and advancements in this field in
the United States have started to gain momentum; most
studies use animal models. One study by Drygas et al.
evaluated a Siberian husky implanted with bilateral tibial
prostheses.The implant comprised a titanium intramedullary
stem and a porous tantalum outer sleeve, inserted in a press-
fit manner. One limb experienced aseptic loosening at 14
months and required reimplantation; however, the animal
was able towalk, trot, and run 26months postoperatively [15].
Although this study is important, it evaluated the prostheses
in tibiae which does not readily translate to the more vertical
alignment of the human leg. We chose the sheep model
because of similarities to humans in both body weight and
bone remodeling capabilities [16, 17]. As stated earlier, the
forelimb of the sheep was chosen due to its vertical alignment
and its ability to more closely mimic the forces experienced
by the human femur [18].
Currently, the greatest contribution to development of an
osseointegrated implant for amputees in the US has come
from the University of Utah and the Veterans’ Affairs Salt
Lake City Health Care System. To date, this group has com-
pleted numerous studies involving animal models, including
sheep, to evaluate implant design. Unlike the osseointegrated
compressive design used in our study, their implant consists
of a press-fit ribbed titanium stem with a porous coated
subcutaneous collar.They have demonstrated good histologic
and radiographic evidence of osseointegration as well as
decreased infection risk from the outside environment [19–
22]. They are currently working toward human trials.
Work underway overseas and at the previously stated US
institution has been promising but compressive osseointegra-
tive technology has the potential to achieve superior results.
The Compress system has been FDA approved since 2003
for use in limb-salvage procedures. It has several advantages
making it an appealing design choice in the development
of new osseointegrated transcutaneous prostheses. First, the
technology is based uponWolff ’s law in which a compressive
force is applied to the bone-implant interface resulting in
bone formation and osseointegration [23]. Not only does
this design eliminate stress shielding from the implant, but
also it seals the intramedullary canal to limit the spread
of ascending medullary infection from the outside envi-
ronment. Over the past few years, the longevity of these
implants has been evaluated in orthopaedic literature. A
recent study byMonument et al. evaluated 18 patients treated
with compressive osseointegration of either the proximal
or distal femur with a minimum of five years of follow-
up. They demonstrated implant survivorship of 88% when
evaluating for aseptic revision and 67% implant survivorship
when including revision for oncologic failure, infection,
arthrofibrosis, andmechanical failure [24]. A study byHealey
et al. showed similar results; they retrospectively reviewed
82 patients treated with the Compress Knee Arthroplasty
for distal femoral replacements. They demonstrated an 85%
implant survival rate at 5 years and 80% survival rate at
10 years. Further, of the failed implants, 62% (8/13) were
the result of failures at the bone/implant interface [25]. In
both studies, most implant failures were observed early in
the postoperative period, with little change in outcome after
the first two years. The other important advantage of these
implants is the minimal amount of bone stock required for
both implantation and removal. A study by Tyler et al. eval-
uated 11 patients who underwent removal of a compressive
osseointegrated device from either the proximal or distal
femur over an 11-year period. Intraoperative measurements
revealed an average bone loss of 8mm with removal of the
implant [9]. Not only do these implants requireminimal bone
stock for implantation, but also they provide the surgeon
with future options if revision surgery is required. The
final advantage is the transcutaneous component of this
device, which is more robust; in our small series, we had
no implant failures. Some may consider the placement of
a Compress device in patients with poor bone quality, as
often seen in transfemoral amputees, to be a risk factor for
periprosthetic fracture; however, this has not been supported
in the literature.[26, 27].
This study has several limitations. First, the number of
animals included in the study is small (N=4). It is difficult to
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ascertain statistically significant conclusions based on these
numbers; however, the ultimate goal of our study was to
obtain data demonstrating the feasibility of this concept.
Based on the data shown, this concept as a transdermal
osseointegrated prosthesis is promising. Second, the follow-
up for this study would be considered short-term at 16 weeks.
However, these initial data allow us to feel positive about
many of the short-term concerns such as acute infection or
implant failure. Third, difficulty maintaining lack of weight
bearing was another limitation not initially anticipated. All
animals immediately ambulated after the initial amputation
and implantation of the spindle. Although the cross pins
through the anchor plug do provide some rotational control,
the device is designed for limited weight bearing until
bony apposition develops along the spindle. Further, this
immediate weight bearing likely contributed to the fractures
seen in two of the animals. This was successfully addressed
with the developed splinting technique. Finally, the last
limitation was the use of both long and short anchor plugs
in a small study; however, there is not published data that
compares one to the other. Although the shorter anchor
plug has been commercially available for quite some time
without any massive clinical failures, one possible advantage
to the use of the shorter plug is in the setting of very little
residual femur; this device can still be used with as little
as approximately 5 cm of bone. This could potentially take
someone who physically acts more like a hip disarticulation,
since the residual limb cannot support a prosthesis, to
a functional extremity. However, the longer plug may be
seen as stronger, since the longer anchor plug creates less
cantilevering leading to a more equally distributed force
across the end of the bone. Future human trials would allow
for more clinically relevant patient-specific outcomes with
minimal risk to the patient and with potential profound
advantages.
Osseointegrated transcutaneous prosthetic devices for
human use are not widely available in the United States
and the current implants being used in other countries
have several features that could be improved. Taking these
limitations into consideration, we felt that the best way to
address these issues, such as osseointegration of the bone-
implant interface, the amount of bone stock required for
implantation/removal, and the sturdiness of the external
prosthesis, could be addressed with an implant utilizing
Compress technology. Our proof-of-concept study, using
a large animal model, demonstrated osseointegration is
possible at the bone-implant interface and no occurrences
of transcutaneous adapter implant failures in a worst-case
scenario. Although our numbers were small and the results
were based on a short time period, the goal of our pilot study
was to obtain initial data as a feasibility study to demonstrate
that this concept has merit.
Subsequent to this animal study being performed, a case
series has been conducted on humans with this device, with
substantial success [28]. These devices have been performed
under the custom regulatory process. There were three com-
plications in 13 patients: two fractures that were revised and
maintained their revised prosthesis and one taper mismatch
which was corrected. No infections were noted in this small
study. Our group intends on collaborating with the FDA IDE
study soon for further investigation.
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